Aktis Oncology, Inc.

AKTS·NasdaqGS·Healthcare
Compare
17.34−0.81 (−4.46%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours17.340.00 (0.00%)Oct 12, 4:01 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close18.15
Open18.12
Day range17.3318.19
52-week range14.7234.19
Off day high−4.67%
Off 52-week high−49.28%
Volume274.05K
Avg. volume (3M)362.71K
Market cap964.44M
EPS (TTM)-1.70
Forward P/E-8.07
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding53.75M
Short interest29.16% of float
Earnings dateNov 12, 2026 (est.)
Analyst target35.39
Profit margin0.00%

Against its peers

Compare in full ›
AKTS ANL KURA RCUS PYXS SNDX
Market cap 964.44M 915.74M 924.75M 3.06B 240.11M 1.48B
P/E (TTM) — — — — — —
Forward P/E -8.1 -48.3 -4.4 -7.5 -1.8 -19.4
Price/book 2.0 4.3 19.1 6.7 11.2 97.9
Dividend yield — — — — — —
1-year change −22.59% +746.43% +6.75% +46.69% −41.16% +11.78%
Today −4.46% −8.96% −1.93% −0.29% −0.99% −2.59%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All AKTS news ›
Markets Daily·

Aktis Oncology $AKTS Stock Purchased by Mirador Capital Partners LP

Posted by Kim Johansen on Oct 10th, 2026 Shares of AKTS stock opened at $18.15 on Friday. The stock has a market capitalization of $975.56 million and a PE ratio of -22.13. The business’s 50 day simple moving average is $22.96 and its 200…

MarketBeat·Positive

Aktis Oncology (NASDAQ:AKTS) Given Outperform Rating at Wedbush

Aktis Oncology (NASDAQ:AKTS - Get Free Report)'s stock had its "outperform" rating reiterated by equities researchers at Wedbush in a research note issued to investors on Friday, Benzinga reports. They presently have a $35.00 price target…

From articles in the 4Search news index.

In the news

7mentions in 30 days
7with it in the headline
Positivesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.